TSS
VRCA icon

Two Sigma Securities’s Verrica Pharmaceuticals VRCA Stock Holding History

Two Sigma Securities’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.8K Buy
+13,045
New +$81.4K 0.01% 1331
2024
Q4 		– Sell
-3,598
Closed -$52.2K – 3275
2024
Q3 		$52.2K Buy
+3,598
New +$162K ﹤0.01% 2373
2024
Q1 		– Sell
-1,004
Closed -$73.5K – 3718
2023
Q4 		$73.5K Buy
+1,004
New +$41.3K ﹤0.01% 2554

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Securities's VRCA Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Verrica Pharmaceuticals (VRCA) in Q2 2026: 13,045 shares worth $79.8K. The stake represents 0.01% of the portfolio and ranks #1331 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in VRCA as recently as Q3 2024.

Two Sigma Securities first reported a position in VRCA in Q4 2023 and has held it in 3 quarters since. 43 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

  • Two Sigma Securities held 13,045 shares of Verrica Pharmaceuticals worth $79.8K as of Q2 2026.
  • Verrica Pharmaceuticals was a new Two Sigma Securities position in Q2 2026.
  • Verrica Pharmaceuticals made up 0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1331 holding.
  • Two Sigma Securities first reported a position in Verrica Pharmaceuticals in Q4 2023 and has held it in 3 quarters since.
  • 43 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.